The Anti-Mullerian Hormone as a Biomarker of Effectiveness of Metformin Hydrochloride Therapy in Polycystic Ovarian Syndrome and Insulin Resistance DOI Open Access
Nikoleta Parahuleva, Anna Mihaylova, Stanislava Harizanova

et al.

Healthcare, Journal Year: 2025, Volume and Issue: 13(8), P. 884 - 884

Published: April 11, 2025

Background/Objectives: Among the therapeutic options available for managing PCOS, metformin improves insulin sensitivity, reduces androgen levels, and helps restore menstrual regularity ovulation. While primarily used its metabolic effects, therapy may also influence reproductive parameters, including AMH which are pivotal in improving ovarian function predicting outcomes PCOS. The aim of this study was to search scientific literature analyze correlation between levels hydrochloride women with PCOS IR. Methods: A systematic review conducted using following keywords: polycystic syndrome, anti-Mullerian hormone, resistance, metformin, treatment, biomarker, syndrome. This aimed at investigating potential as a biomarker effectiveness patients Results: Metformin treatment has shown significant reductions serum prolonged therapy. As an sensitizer, hyperinsulinemia, suppresses hyperandrogenism. process inhibits growth antral follicles, is reflected decreased levels. Conclusions: Reductions improvements sensitivity can serve indicators efficacy enhancements these patients. could be considered prognostic marker evaluating decrease indicate improved reduction morphology. However, further research necessary confirm findings determine optimal dosages duration treatment.

Language: Английский

The Anti-Mullerian Hormone as a Biomarker of Effectiveness of Metformin Hydrochloride Therapy in Polycystic Ovarian Syndrome and Insulin Resistance DOI Open Access
Nikoleta Parahuleva, Anna Mihaylova, Stanislava Harizanova

et al.

Healthcare, Journal Year: 2025, Volume and Issue: 13(8), P. 884 - 884

Published: April 11, 2025

Background/Objectives: Among the therapeutic options available for managing PCOS, metformin improves insulin sensitivity, reduces androgen levels, and helps restore menstrual regularity ovulation. While primarily used its metabolic effects, therapy may also influence reproductive parameters, including AMH which are pivotal in improving ovarian function predicting outcomes PCOS. The aim of this study was to search scientific literature analyze correlation between levels hydrochloride women with PCOS IR. Methods: A systematic review conducted using following keywords: polycystic syndrome, anti-Mullerian hormone, resistance, metformin, treatment, biomarker, syndrome. This aimed at investigating potential as a biomarker effectiveness patients Results: Metformin treatment has shown significant reductions serum prolonged therapy. As an sensitizer, hyperinsulinemia, suppresses hyperandrogenism. process inhibits growth antral follicles, is reflected decreased levels. Conclusions: Reductions improvements sensitivity can serve indicators efficacy enhancements these patients. could be considered prognostic marker evaluating decrease indicate improved reduction morphology. However, further research necessary confirm findings determine optimal dosages duration treatment.

Language: Английский

Citations

1